WELLS FARGO & COMPANY/MN - ALDER BIOPHARMACEUTICALS INC ownership

ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 48 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of ALDER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$5,771,000
+227.3%
433,263
+151.2%
0.00%
Q2 2019$1,763,000
-4.0%
172,506
+28.2%
0.00%
-100.0%
Q1 2019$1,836,000
+37.8%
134,521
-51.7%
0.00%
Q4 2018$1,332,000
-56.9%
278,663
-11.1%
0.00%
-100.0%
Q3 2018$3,092,000
-10.6%
313,576
+21.7%
0.00%0.0%
Q2 2018$3,457,000
+82.9%
257,616
+73.1%
0.00%0.0%
Q1 2018$1,890,000
+54.5%
148,791
+39.3%
0.00%
Q4 2017$1,223,000
-42.2%
106,806
-38.2%
0.00%
-100.0%
Q3 2017$2,117,000
+36.8%
172,897
+28.0%
0.00%
Q2 2017$1,547,000
-26.8%
135,071
+33.0%
0.00%
-100.0%
Q1 2017$2,113,000
-72.7%
101,545
-72.7%
0.00%
-66.7%
Q4 2016$7,750,000
-9.8%
372,619
+42.1%
0.00%0.0%
Q3 2016$8,591,000
-38.8%
262,182
-53.3%
0.00%
-40.0%
Q2 2016$14,027,000
+107.5%
561,722
+103.5%
0.01%
+66.7%
Q1 2016$6,760,000
-24.1%
276,059
+2.3%
0.00%
-25.0%
Q4 2015$8,911,000
+293.9%
269,774
+290.6%
0.00%
+300.0%
Q3 2015$2,262,000
-39.8%
69,067
-2.6%
0.00%0.0%
Q2 2015$3,758,000
+11.2%
70,924
-39.4%
0.00%0.0%
Q1 2015$3,380,000
+1501.9%
117,110
+1516.9%
0.00%
Q4 2014$211,000
-41.1%
7,243
-74.3%
0.00%
Q3 2014$358,000
-53.4%
28,225
-26.3%
0.00%
Q2 2014$769,00038,3230.00%
Other shareholders
ALDER BIOPHARMACEUTICALS INC shareholders Q2 2014
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 1,628,328$33,869,00014.72%
Foresite Capital Management II, LLC 995,396$20,704,00010.39%
Cormorant Asset Management, LP 1,581,604$32,897,0004.43%
DAFNA Capital Management LLC 221,013$4,597,0004.04%
New Leaf Venture Partners, L.L.C. 228,428$4,751,0003.40%
Partner Investment Management, L.P. 63,571$1,322,0001.75%
Iguana Healthcare Management, LLC 140,000$2,912,0001.74%
PFM Health Sciences, LP 2,913,951$60,610,0001.71%
Redmile Group, LLC 920,550$19,147,0001.65%
SECTORAL ASSET MANAGEMENT INC 669,351$13,923,0001.54%
View complete list of ALDER BIOPHARMACEUTICALS INC shareholders